SANUWAVE Health, Inc. Proceeds from Sale of Productive Assets
SANUWAVE Health, Inc. (SNWV) reported Proceeds from Sale of Productive Assets of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2025-03-20
- SANUWAVE Health, Inc. proceeds from sale of productive assets for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SANUWAVE Health, Inc. proceeds from sale of productive assets for the quarter ending 2023-12-31 was $8.00K.
- SANUWAVE Health, Inc. proceeds from sale of productive assets for the quarter ending 2023-09-30 was $13.00K, a 82.43% decline year-over-year.
- SANUWAVE Health, Inc. proceeds from sale of productive assets for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- SANUWAVE Health, Inc. proceeds from sale of productive assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SANUWAVE Health, Inc. proceeds from sale of productive assets for fiscal 2023 was $21.00K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |||
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $21.00K derived: sum of 2 quarters · filed 2025-03-20 | $21.00K derived: sum of 3 quarters · filed 2025-03-20 | $21.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $13.00K derived: sum of 2 quarters · filed 2024-11-07 | $13.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2022-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $662.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.02M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $588.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $948.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $360.00K 10-Q · filed 2023-05-11 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |